223 related articles for article (PubMed ID: 8328993)
1. Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections.
Jouen F; Verité P; André D; Colonna L; Boucly P
Arzneimittelforschung; 1993 May; 43(5):509-11. PubMed ID: 8328993
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B
J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
[TBL] [Abstract][Full Text] [Related]
3. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
Wiles DH; Gelder MG
Adv Biochem Psychopharmacol; 1980; 24():599-602. PubMed ID: 7405678
[No Abstract] [Full Text] [Related]
4. Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine.
Marder SR; Van Putten T; Aravagiri M; Hubbard JW; Hawes EM; McKay G; Midha KK
Psychopharmacol Bull; 1989; 25(3):479-82. PubMed ID: 2626520
[TBL] [Abstract][Full Text] [Related]
5. Monitoring plasma levels of fluphenazine during chronic therapy with fluphenazine decanoate.
Miller RS; Peterson GM; McLean S; Westhead TT; Gillies P
J Clin Pharm Ther; 1995 Apr; 20(2):55-62. PubMed ID: 7650075
[TBL] [Abstract][Full Text] [Related]
6. Fluphenazine blood levels and clinical response.
Harris PQ; Friedman MJ; Cohen BM; Cooper TB
Biol Psychiatry; 1982 Oct; 17(10):1123-30. PubMed ID: 7171656
[TBL] [Abstract][Full Text] [Related]
7. Picogram level determination of fluphenazine in human plasma by automated gas chromatography/mass selective detection.
Jemal M; Ivashkiv E; Both D; Koski R; Cohen AI
Biomed Environ Mass Spectrom; 1987 Dec; 14(12):699-704. PubMed ID: 3435791
[TBL] [Abstract][Full Text] [Related]
8. [Outcome in 64 chronic psychotics treated with delayed action Moditen or Modecate].
Bastie Y
Ann Med Psychol (Paris); 1974 Apr; 1(4):531-6. PubMed ID: 4605833
[No Abstract] [Full Text] [Related]
9. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
Tsutsul'kovskaia MIa; Minsker EI; Panteleeva GP; Mazurskii MB; Pekunova LG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):753-8. PubMed ID: 4718619
[No Abstract] [Full Text] [Related]
10. Clinical pharmacokinetics of the depot antipsychotics.
Jann MW; Ereshefsky L; Saklad SR
Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156
[TBL] [Abstract][Full Text] [Related]
11. Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate.
Marder SR; Hubbard JW; Van Putten T; Hawes EM; McKay G; Mintz J; May PR; Midha KK
Psychopharmacol Bull; 1986; 22(1):264-6. PubMed ID: 3726072
[No Abstract] [Full Text] [Related]
12. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
Haumonté MT; Hoerdt HP
Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
[No Abstract] [Full Text] [Related]
13. Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine.
Aravagiri M; Marder SR; Van Putten T; Hawes EM; McKay G; Midha KK
Ther Drug Monit; 1994 Feb; 16(1):21-9. PubMed ID: 8160250
[TBL] [Abstract][Full Text] [Related]
14. Fluphenazine determination in human plasma by a sensitive gas chromatographic method using nitrogen detector.
Javaid JI; Dekirmenjian H; Liskevych U; Lin RL; Davis JM
J Chromatogr Sci; 1981 Sep; 19(9):439-43. PubMed ID: 7298790
[TBL] [Abstract][Full Text] [Related]
15. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
Wiles DH; Gelder MG
Br J Clin Pharmacol; 1979 Dec; 8(6):565-70. PubMed ID: 533577
[TBL] [Abstract][Full Text] [Related]
16. Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study.
Dudley J; Rauw G; Hawes EM; Keegan DL; Midha KK
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):791-5. PubMed ID: 6686710
[TBL] [Abstract][Full Text] [Related]
17. Sensitive method for the simultaneous measurement of fluphenazine decanoate and fluphenazine in plasma by high-performance liquid chromatography with coulometric detection.
Luo JP; Hubbard JW; Midha KK
J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):303-8. PubMed ID: 9061468
[TBL] [Abstract][Full Text] [Related]
18. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
Viala A; Hou N; Ba B; Durand A; Dufour H; D'Agostino N; Berda C; Jørgensen A
Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of fluphenazine decanoate. Effects of site of injection, massage and muscle activity.
Soni SD; Wiles D; Schiff AA; Bamrah JS
Br J Psychiatry; 1988 Sep; 153():382-4. PubMed ID: 3250675
[TBL] [Abstract][Full Text] [Related]
20. Determination of fluphenazine, related phenothiazine drugs and metabolites by combined high-performance liquid chromatography and radioimmunoassay.
Goldstein SA; Van Vunakis H
J Pharmacol Exp Ther; 1981 Apr; 217(1):36-43. PubMed ID: 6110775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]